Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: A systematic review
- PMID: 37194205
- DOI: 10.1002/hed.27401
Influence of time between surgery and adjuvant radiotherapy on prognosis for patients with head and neck squamous cell carcinoma: A systematic review
Abstract
The timing of postoperative radiotherapy following surgical intervention in patients with head and neck cancer remains a controversial issue. This review aims to summarize findings from available studies to investigate the influence of time delays between surgery and postoperative radiotherapy on clinical outcomes. Articles between 1 January 1995 and 1 February 2022 were sourced from PubMed, Web of Science, and ScienceDirect. Twenty-three articles met the study criteria and were included; ten studies showed that delaying postoperative radiotherapy might negatively impact patients and lead to a poorer prognosis. Delaying the start time of radiotherapy, 4 weeks after surgery did not result in poorer prognoses for patients with head and neck cancer, although delays beyond 6 weeks might worsen patients' overall survival, recurrence-free survival, and locoregional control. Prioritization of treatment plans to optimize the timing of postoperative radiotherapy regimes is recommended.
Keywords: head and neck squamous cell carcinoma; patient prognosis; postoperative radiotherapy; radiotherapy; time interval.
© 2023 The Authors. Head & Neck published by Wiley Periodicals LLC.
References
REFERENCES
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
-
- Wang Y, Wang M, Tang Y, Sun B, Wang K, Zhu F. Perioperative mortality of head and neck cancers. BMC Cancer. 2021;21(1):256.
-
- Riva G, Albano C, Gugliesi F, et al. HPV meets APOBEC: new players in head and neck cancer. Int J Mol Sci. 2021;22(3):1402.
-
- Spence T, Bruce J, Yip KW, Liu FF. HPV associated head and neck cancer. Cancer. 2016;8(8):75.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
